- Home
- ULS vs FMS Comparison
ULS vs FMS Comparison
Compare ULS & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULS
- FMS
- Stock Information
- Founded
- ULS 1894
- FMS 1996
- Country
- ULS United States
- FMS Germany
- Employees
- ULS N/A
- FMS 109916
- Industry
- ULS
- FMS Misc Health and Biotechnology Services
- Sector
- ULS
- FMS Health Care
- Exchange
- ULS Nasdaq
- FMS Nasdaq
- Market Cap
- ULS 15.8B
- FMS 14.1B
- IPO Year
- ULS 2024
- FMS 1996
- Fundamental
- Price
- ULS $85.09
- FMS $23.99
- Analyst Decision
- ULS Hold
- FMS Sell
- Analyst Count
- ULS 8
- FMS 2
- Target Price
- ULS $78.75
- FMS $30.00
- AVG Volume (30 Days)
- ULS 595.6K
- FMS 439.9K
- Earning Date
- ULS 11-04-2025
- FMS 11-04-2025
- Dividend Yield
- ULS 0.61%
- FMS 2.38%
- EPS Growth
- ULS 10.58
- FMS 8.40
- EPS
- ULS 1.67
- FMS 2.86
- Revenue
- ULS $3,003,000,000.00
- FMS $23,046,819,198.00
- Revenue This Year
- ULS $6.79
- FMS $1.75
- Revenue Next Year
- ULS $6.23
- FMS $3.01
- P/E Ratio
- ULS $50.90
- FMS $16.47
- Revenue Growth
- ULS 6.68
- FMS 2.10
- 52 Week Low
- ULS $48.54
- FMS $21.06
- 52 Week High
- ULS $91.95
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- ULS 68.51
- FMS 27.16
- Support Level
- ULS $76.84
- FMS $23.50
- Resistance Level
- ULS $91.95
- FMS $24.63
- Average True Range (ATR)
- ULS 2.44
- FMS 0.40
- MACD
- ULS 0.44
- FMS -0.41
- Stochastic Oscillator
- ULS 58.70
- FMS 12.31
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.